Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
暂无分享,去创建一个
R. Califf | I. Piña | C. O'connor | M. Gheorghiade | B. Massie | K. Adams | R. Benza | M. Silver | W. Colucci | R. Bourge | M. Cuffe | R. Quigg
[1] E. Antman,et al. ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .
[2] P. Lapuerta,et al. A health perception score predicts cardiac events in patients with heart failure: results from the IMPRESS trial. , 2001, Journal of cardiac failure.
[3] R. Califf,et al. Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. , 2000, American heart journal.
[4] I. Piña,et al. Tolerability of extended duration intravenous milrinone in patients hospitalized for advanced heart failure and the usefulness of uptitration of oral angiotensin-converting enzyme inhibitors. , 1999, The American journal of cardiology.
[5] J. Croft,et al. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. , 1999, American heart journal.
[6] R. Quigg,et al. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure. , 1998, The American journal of cardiology.
[7] B. Massie,et al. Optimizing therapy for complex or refractory heart failure: a management algorithm. , 1998, American heart journal.
[8] R. Bonow,et al. Chronic heart failure in the United States: a manifestation of coronary artery disease. , 1998, Circulation.
[9] J. Feinglass,et al. Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center. , 1997, American heart journal.
[10] R. Bonow,et al. Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials. , 1997, The American journal of cardiology.
[11] J. Feinglass,et al. Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. , 1997, American heart journal.
[12] L. Goldman,et al. Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. , 1996, Archives of internal medicine.
[13] M. Hess,et al. Milrinone: basic and clinical pharmacology and acute and chronic management. , 1996, The American journal of the medical sciences.
[14] M. Bristow,et al. Economic impact of heart failure in the United States: time for a different approach. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[15] D. Levy,et al. The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.
[16] M D Hughes,et al. Reporting Bayesian analyses of clinical trials. , 1993, Statistics in medicine.
[17] J. Cohn,et al. Effect of Enalapril, Hydralazine Plus Isosorbide Dinitrate, and Prazosin on Hospitalization in Patients With Chronic Congestive Heart Failure , 1993, Circulation.
[18] P E Leaverton,et al. Prevalence and mortality rate of congestive heart failure in the United States. , 1992, Journal of the American College of Cardiology.
[19] D. DeMets,et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.
[20] M. Rich,et al. Early Readmission of Elderly Patients With Congestive Heart Failure , 1990, Journal of the American Geriatrics Society.
[21] R. Cooper,et al. Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. , 1990, Archives of internal medicine.
[22] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[23] R. A. Johnson,et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. , 1982, The New England journal of medicine.